10 Biggest Price Target Changes For Friday
- Credit Suisse raised Esperion Therapeutics Inc (NASDAQ: ESPR) price target from $10 to $14. Esperion Therapeutics shares closed at $13.01 on Thursday.
- Citi raised the price target for Progressive Corp (NYSE: PGR) from $30 to $34. Progressive shares closed at $32.48 on Thursday.
- Barclays raised the price target for Paypal Holdings Inc (NASDAQ: PYPL) from $42 to $47. Paypal shares closed at $39.20 on Thursday.
- Goldman Sachs lowered the price target for Hortonworks Inc (NASDAQ: HDP) from $13 to $7. Hortonworks shares closed at $7.17 on Thursday.
- BTIG raised the price target on bluebird bio Inc (NASDAQ: BLUE) from $72 to $83. bluebird shares closed at $65.24 on Thursday.
- Bank of America increased the price target on Terex Corporation (NYSE: TEX) from $21 to $29. Terex shares closed at $23.89 on Thursday.
- Baird lowered Henry Schein, Inc. (NASDAQ: HSIC) price target from $176 to $164. Henry Schein shares closed at $156.05 on Thursday.
- RBC Capital raised ConAgra Foods Inc (NYSE: CAG) price target from $50 to $54. ConAgra shares closed at $46.92 on Thursday.
- Wunderlich cut price target for Aerohive Networks Inc (NYSE: HIVE) from $8 to $5. Aerohive shares closed at $5.63 on Thursday.
- Deutsche Bank lowered the price target for Invesco Ltd. (NYSE: IVZ) from $36 to $32. Invesco shares closed at $30.31 on Thursday.
Latest Ratings for ESPR
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 2021 | B of A Securities | Downgrades | Buy | Neutral |
| Nov 2020 | Credit Suisse | Upgrades | Neutral | Outperform |
| Oct 2020 | B of A Securities | Maintains | Buy |
View More Analyst Ratings for ESPR
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Price Target ChangesPrice Target Analyst Ratings
